The study was conducted during a 1-month time frame.Patients were visited, as usual, by their oncologists before theadministration of chemotherapy, and then informed by the oncol-ogy nurse of the possibility to participate in the study. OnMondays and Wednesdays of each week, the first consecutiveeligible patients of the day who gave their informed consentto participate in the study were placed in the same room forchemotherapy infusion and took part in the experimental group.On Tuesdays and Thursdays the same procedure was followedand these patients were assigned to the control groups. 31patients were allocated to the experimental group and 31 to thecontrol group.